Active Ingredient: BUPRENORPHINE HYDROCHLORIDE
Proprietary Name: BUPRENORPHINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A201066
Product Number: 001
Approval Date: Mar 6, 2015
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
Active Ingredient: BUPRENORPHINE HYDROCHLORIDE
Proprietary Name: BUPRENORPHINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: EQ 8MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A201066
Product Number: 002
Approval Date: Mar 6, 2015
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information